Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 문홍상 | - |
dc.date.accessioned | 2019-03-22T07:45:30Z | - |
dc.date.available | 2019-03-22T07:45:30Z | - |
dc.date.issued | 2016-11 | - |
dc.identifier.citation | Urogenital Tract Infection, v. 11, NO 3, Page. 103-108 | en_US |
dc.identifier.issn | 2465-8243 | - |
dc.identifier.issn | 2465-8510 | - |
dc.identifier.uri | https://synapse.koreamed.org/DOIx.php?id=10.14777/uti.2016.11.3.103 | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/101103 | - |
dc.description.abstract | Purpose: CC-chemokine ligand 11 (CCL11; eotaxin-1), an eosinophil chemoattractant chemokine, has been proposed as a serum marker for prostate cancer (PCa) by two research groups. We investigated the usefulness of CCL11 in diagnosing prostatic diseases, such as benign prostatic hyperplasia (BPH) and PCa. Materials and Methods: CCL11 was measured in the sera of 139 men with BPH, 44 men with PCa, and 45 control men attending an outpatient health-screening clinic. A commercial enzyme-linked immunosorbent assay kit was used to measure CCL11. Results: CCL11 concentrations were significantly higher in men with BPH and PCa than in normal men (72.9±3.15 and 80.0±4.91 pg/ml vs. 57.6±8.24). In addition, a receiver operating characteristic (ROC) analysis of serum CCL11 levels showed that the areas under the ROC curves were 0.661 (p=0.001) and 0.654 (p=0.012) for BPH and PCa, respectively, compared with normal men. Conclusions: CCL11 may be helpful in diagnosing prostatic diseases, such as BPH and PCa. | en_US |
dc.description.sponsorship | This work was supported by the research fund of Hanyang University (HY-2012) and by the National Research Foundation of Korea (NRF) funded by the Korean Government (MSIP) (NRF-2014R1A2A2A01005449). | en_US |
dc.language.iso | en | en_US |
dc.publisher | 대한요로생식기감염학회 | en_US |
dc.subject | Chemokine CCL11 | en_US |
dc.subject | Prostatic hyperplasia | en_US |
dc.subject | Prostatic neoplasms | en_US |
dc.title | Serum CCL11 Levels in Benign Prostatic Hyperplasia and Prostate Cancer | en_US |
dc.type | Article | en_US |
dc.relation.no | 3 | - |
dc.relation.volume | 11 | - |
dc.identifier.doi | https://doi.org/10.14777/uti.2016.11.3.103 | - |
dc.relation.page | 103-108 | - |
dc.relation.journal | Urogenital Tract Infection | - |
dc.contributor.googleauthor | Kim, Kyu-Shik | - |
dc.contributor.googleauthor | Moon, Hong-Sang | - |
dc.contributor.googleauthor | Park, Sung-Yul | - |
dc.contributor.googleauthor | Hwang, Hwan-Sik | - |
dc.contributor.googleauthor | Kim, Jung-Hyun | - |
dc.contributor.googleauthor | Kim, Sang-Su | - |
dc.contributor.googleauthor | Han, Ik-Hwan | - |
dc.contributor.googleauthor | Kim, Ki-Jun | - |
dc.contributor.googleauthor | Noh, Chang-Suk | - |
dc.contributor.googleauthor | Ryu, Jae-Sook | - |
dc.relation.code | 2016042963 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | moonuro | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.